World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
12933
World Ranking
13733
National Ranking
30

Overview

Petros I. Rafailidis is affiliated with Democritus University of Thrace in Greece and has contributed extensively to the field of Medicine, with a particular focus on Infectious Diseases, Applied Microbiology and Biotechnology, Pharmacology, Neurology, and Immunology. Their research emphasizes antibiotic resistance, infectious disease management, and immunological mechanisms related to bacterial infections and COVID-19.

Their frequent research topics include:

  • Antibiotic Use and Resistance
  • COVID-19 Clinical Research Studies
  • Antibiotic Resistance in Bacteria
  • Neutrophil, Myeloperoxidase and Oxidative Mechanisms
  • Inflammasome and Immune Disorders
  • Antibiotics Pharmacokinetics and Efficacy
  • Nosocomial Infections in ICU

Rafailidis has collaborated regularly with several coauthors, including:

  • Vasileios Petrakis (9 collaborations)
  • Dimitrios Papazoglou (8 collaborations)
  • Maria Panopoulou (7 collaborations)
  • Periklis Panagopoulos (6 collaborations)
  • Irene Terzi (6 collaborations)

Their publications appear predominantly in these venues:

  • Infezioni in Medicina (3 papers)
  • bioRxiv (Cold Spring Harbor Laboratory) (2 papers)
  • Expert Review of Anti-infective Therapy (2 papers)
  • Virology (2 papers)
  • Journal of Clinical Investigation (1 paper)

Key recent papers authored or coauthored by Rafailidis include:

  • "Proposed amendments regarding the definitions of multidrug-resistant and extensively drug-resistant bacteria," 2021, Expert Review of Anti-infective Therapy
  • "Current Therapeutic Approaches for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Infections," 2024, Antibiotics

Additional notable papers associated with their frequent collaborators, particularly related to COVID-19, include:

  • "Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis," 2020, Journal of Clinical Investigation
  • "Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections," 2023, Pathogens

Rafailidis's work addresses complex interactions between infectious agents and immune responses, with particular attention to multidrug-resistant bacteria and clinical therapeutic strategies. Their research also explores the implications of the COVID-19 pandemic on antimicrobial resistance dynamics and infection control in clinical settings.

Best Publications

  • Severe cytomegalovirus infection in apparently immunocompetent patients: a systematic review.

    Petros I Rafailidis;Eleni G Mourtzoukou;Ioannis C Varbobitis;Matthew E Falagas;Matthew E Falagas

  • Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis.

    Panagiotis Skendros;Alexandros Mitsios;Akrivi Chrysanthopoulou;Dimitrios C. Mastellos

  • β-D-Glucan Assay for the Diagnosis of Invasive Fungal Infections: A Meta-analysis

    Drosos E. Karageorgopoulos;Evridiki K. Vouloumanou;Fotinie Ntziora;Argyris Michalopoulos

  • Antibiotic Treatment of Infections Due to Carbapenem-Resistant Enterobacteriaceae: Systematic Evaluation of the Available Evidence

    Matthew E. Falagas;Panagiota Lourida;Panagiotis Poulikakos;Petros I. Rafailidis

  • Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae producing extended-spectrum β-lactamases: a systematic review and meta-analysis

    Konstantinos Z. Vardakas;Giannoula S. Tansarli;Petros I. Rafailidis;Matthew E. Falagas;Matthew E. Falagas

  • Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal Infections

    Matthew E. Falagas;Konstantina P. Giannopoulou;George N. Kokolakis;Petros I. Rafailidis

  • Colistin therapy for microbiologically documented multidrug-resistant Gram-negative bacterial infections: a retrospective cohort study of 258 patients

    Matthew E. Falagas;Matthew E. Falagas;Petros I. Rafailidis;Elda Ioannidou;Vangelis G. Alexiou

  • Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence

    Theodore Kelesidis;Iosif Kelesidis;Petros I. Rafailidis;Matthew E. Falagas;Matthew E. Falagas

  • Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case–control study

    Matthew E Falagas;Matthew E Falagas;Petros I Rafailidis;Diamantis Kofteridis;Simona Virtzili

  • Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence.

    Konstantinos Z. Vardakas;Konstantinos A. Polyzos;Konstantina Patouni;Petros I. Rafailidis

  • Attributable mortality of Acinetobacter baumannii: no longer a controversial issue

    Matthew E Falagas;Petros I Rafailidis

  • Worldwide prevalence of head lice.

    Matthew E. Falagas;Dimitrios K. Matthaiou;Petros I. Rafailidis;George Panos

  • The effect of psychosocial factors on breast cancer outcome: a systematic review.

    Matthew E Falagas;Matthew E Falagas;Effie A Zarkadoulia;Eleni N Ioannidou;George Peppas

  • Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study

    Nikolaos Markou;Sophia L Markantonis;Efthimios Dimitrakis;Dimitris Panidis

  • Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: a systematic review of microbiological, animal and clinical studies

    Matthew E. Falagas;Matthew E. Falagas;Antonia C. Kastoris;Drosos E. Karageorgopoulos;Petros I. Rafailidis

  • Intravenous fosfomycin for the treatment of nosocomial infections caused by carbapenem-resistant Klebsiella pneumoniae in critically ill patients: a prospective evaluation

    A. Michalopoulos;S. Virtzili;P. Rafailidis;G. Chalevelakis

  • Fosfomycin versus other antibiotics for the treatment of cystitis: a meta-analysis of randomized controlled trials

    Matthew E. Falagas;Evridiki K. Vouloumanou;Antonios G. Togias;Maria Karadima

  • Antibiotics versus placebo in the treatment of women with uncomplicated cystitis: a meta-analysis of randomized controlled trials.

    Matthew E. Falagas;Ioannis K. Kotsantis;Evridiki K. Vouloumanou;Petros I. Rafailidis

  • Predictors of mortality in patients with infections due to multi-drug resistant Gram negative bacteria: The study, the patient, the bug or the drug?

    Konstantinos Z. Vardakas;Petros I. Rafailidis;Athanasios A. Konstantelias;Athanasios A. Konstantelias;Matthew E. Falagas;Matthew E. Falagas

  • Risk factors associated with the isolation of colistin-resistant gram-negative bacteria: a matched case-control study.

    Dimitrios K. Matthaiou;Argyris Michalopoulos;Petros I. Rafailidis;Drosos E. Karageorgopoulos

Frequent Co-Authors

Matthew E. Falagas
Matthew E. Falagas Alfa Institute of Biomedical Sciences
George Dimopoulos
George Dimopoulos National and Kapodistrian University of Athens
Paschalis Sideras
Paschalis Sideras Academy of Athens
George Samonis
George Samonis University of Crete
Dimitrios T. Boumpas
Dimitrios T. Boumpas National and Kapodistrian University of Athens
John D. Lambris
John D. Lambris University of Pennsylvania
Jordi Rello
Jordi Rello Instituto de Salud Carlos III
George V. Papatheodoridis
George V. Papatheodoridis National and Kapodistrian University of Athens

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in expanding your career options with a background in Biology or Biochemistry? Many students are now turning to flexible programs that align with their goals and schedules. For those seeking to enter healthcare quickly, enrolling in an online medical assisting school is a popular first step. These programs often offer financial aid and can prepare you for immediate employment in clinical settings.

If you’re already a medical assistant, you might consider an medical assistant to lpn bridge program. This pathway can lead to broader responsibilities and higher earning potential by helping you become a Licensed Practical Nurse (LPN).

For those interested in more in-depth science, earning a bs in biology online could open doors to research, laboratory work, or further graduate studies. Likewise, pursuing an online asn is an excellent way to start a nursing career with the flexibility that online learning provides.

With these diverse online pathways, you can tailor your education to meet your career goals in the fields of biology, biochemistry, and healthcare.

Best Scientists Citing Petros I. Rafailidis

Trending Scientists

Recently Published Articles